Last checked at 18 Jan 2023 07:00
FOR RELEASE ON | 18 January 2023 |
IP Group plc - Appointment of Anita Kidgell as Non-executive Director
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops world-changing science and technology businesses, is delighted to announce the appointment of Anita Kidgell as an independent Non-executive Director with effect from 18 January 2023.
Ms Kidgell is currently Head of Corporate Strategy at GSK plc, one of the world's leading healthcare companies and brings to the Board a rare combination of a scientific background together with strategic and communication experience in a leading listed company. Ms Kidgell has spent the bulk of her career at GSK in a number of roles including clinical research, science and product communications, strategy and investor relations.
Sir Douglas Flint, Chairman of IP Group, said: "We are delighted to welcome Anita to the Board, where her experience in strategic development within the life sciences sector and in investor communication will add a fresh dimension to existing strengths on the Board. Her involvement in working at the heart of one of life science's leading listed companies will be invaluable to IP Group as we develop."
This announcement is made pursuant to Listing Rule 9.6.11R. There are no other details required to be disclosed under Listing Rule 9.6.13R. There are no further disclosures required under the Disclosure and Transparency Rules.
For more information, please contact:
IP Group plc | www.ipgroupplc.com |
Liz Vaughan-Adams, Communications | +44 (0) 20 7444 0062/+44 (0) 7967 312125 |
Portland | |
Vic Wallin | +44 (0) 7973 823 119 |
Alex Donaldson | +44 (0) 7516 729 702 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS